I
Ibrahim Turker
Researcher at University of Balamand
Publications - 45
Citations - 714
Ibrahim Turker is an academic researcher from University of Balamand. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 12, co-authored 44 publications receiving 597 citations. Previous affiliations of Ibrahim Turker include Georgia Regents University & Başkent University.
Papers
More filters
Journal ArticleDOI
Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals
Eran Ben-Arye,Eran Ben-Arye,Noah Samuels,Noah Samuels,Lee H. Goldstein,Kamer Mutafoglu,Suha Omran,Elad Schiff,Haris Charalambous,Tahani Dweikat,Ibtisam Ghrayeb,Gil Bar-Sela,Ibrahim Turker,Azza Hassan,Esmat Hassan,Bashar Saad,Omar Nimri,Rejin Kebudi,Michael Silbermann +18 more
TL;DR: The authors assessed the use of herbal medicine by Middle Eastern patients with cancer, as reported by their oncology health care professionals (HCPs), and identified herbal products identified by HCPs.
Journal ArticleDOI
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO).
Bulent Cetin,Mustafa Benekli,Ibrahim Turker,Lokman Koral,Arife Ulas,Faysal Dane,Berna Oksuzoglu,Mehmet Ali Kaplan,Dogan Koca,Cem Boruban,Burcak Yilmaz,Alper Sevinc,Veli Berk,Dogan Uncu,Hakan Harputluoglu,Ugur Coskun,Suleyman Buyukberber +16 more
TL;DR: Lapatinib and capecitabine combination therapy is effective and well tolerated in patients with MBC who had progressive disease after trastuzumab, taxane, and/or anthracycline therapy, as evidenced by this retrospective evaluation.
Journal ArticleDOI
Metaplastic Breast Carcinoma: Case Series and Review of the Literature
Onur Esbah,Fatma Paksoy Turkoz,Ibrahim Turker,Ayse Durnali,Ahmet Siyar Ekinci,Oznur Bal,Özlem Sönmez,Burcin Budakoglu,Ulku Yalcintas Arslan,Berna Oksuzoglu +9 more
TL;DR: Metaplastic breast carcinoma is a rare and orphan disease without standardized treatment approaches and the prognosis is poor so that larger studies to investigate different treatment schedules are urgently needed.
Journal ArticleDOI
Evaluating Palliative Care Needs in Middle Eastern Countries
Michael Silbermann,Regina M. Fink,Sung-Joon Min,Mary P. Mancuso,Jeannine M. Brant,Ramzi R. Hajjar,Nesreen Al-Alfi,Lea Baider,Ibrahim Turker,Karima Elshamy,Ibtisam Ghrayeb,Mazin Faisal Al-Jadiry,Khaled Khader,Sultan Kav,Haris Charalambous,Ruchan Uslu,Rejin Kebudi,Gil Bar-Sela,Nilgün Kuruku,Kamer Mutafoglu,Gulsin Ozalp-Senel,Amitai Oberman,Livia Kislev,Mohammad Khleif,Neophyta Keoppi,Sophia Nestoros,Rasha Fahmi Abdalla,Maryam Rassouli,Amira Morag,Ron Sabar,Omar Nimri,Mohammad Al-Qadire,Murad Alkhalaileh,Mona Tayyem,Myrna A. A. Doumit,Rehana Punjwani,Osaid Rasheed,Fatimah Fallatah,Gulbeyaz Can,Jamila Ahmed,Debbie Strode +40 more
TL;DR: The majority of Middle Eastern patients with cancer are treated in outlying regions; the community is pivotal and must be incorporated into future plans for developing palliative care services.
Journal ArticleDOI
Breast cancer subtypes and outcomes of central nervous system metastases
Ulku Yalcintas Arslan,Berna Oksuzoglu,Sercan Aksoy,Hakan Harputluoglu,Ibrahim Turker,Yavuz Ozisik,Omer Dizdar,Kadri Altundag,Necati Alkis,Nurullah Zengin +9 more
TL;DR: New and effective treatment strategies are required for breast carcinoma patients with brain metastasis considering the positive effect of the treatment on survival, as well as independent prognostic factors for increasing survival after CNS metastasis.